Erin Burkhart
Net worth: 1 M $ as of 2026-08-30
Net worth: 1 M $ as of 2026-08-30
Erin E.
Burkhart is Chief Accounting Officer, Senior VP & Controller at Gilead Sciences, Inc. starting in 2025.
Former roles include Chief Accounting Officer & Group Vice President at BioMarin Pharmaceutical, Inc. from 2022 to 2025, and Associate VP-US Gross-to-Net Business Analysis at Eli Lilly & Co. from 2021 to 2022.
Education includes undergraduate studies at Butler University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-05-19 | 14,173 ( 0.01% ) | 924 505 $ | 2026-08-30 | |
| 2026-09-21 | 1,455 ( 0% ) | 212 925 $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| GILEAD SCIENCES, INC. | Comptroller/Controller/Auditor | 2025-09-21 |
| Companies | Position | End |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Comptroller/Controller/Auditor | 2025-09-01 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2022-03-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Butler University
Butler University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions